1.5.1.25: thiomorpholine-carboxylate dehydrogenase
This is an abbreviated version!
For detailed information about thiomorpholine-carboxylate dehydrogenase, go to the full flat file.
Word Map on EC 1.5.1.25
-
1.5.1.25
-
thyroid
-
nadph-dependent
-
bioavailability
-
cerebral
-
unsaturated
-
ovine
-
l-cystathionine
- 1.5.1.25
-
thyroid
-
nadph-dependent
-
bioavailability
- cerebral
-
unsaturated
-
ovine
- l-cystathionine
Reaction
Synonyms
CRYM, CtBP, cytosolic thyroid hormone binding protein, DELTA1-piperideine-2-carboxylate reductase, ketimine reductase, ketimine-reducing enzyme, KR/CRYM/CTBP, More, mu-crystallin, P2C reductase, PLP-dependent amino acid gamma-substitution enzyme, PYCR2, Pyr2C reductase, reductase, ketimine, THBP, thyroid hormone binding protein, Thyroid hormone-binding protein
ECTree
Advanced search results
Source Tissue
Source Tissue on EC 1.5.1.25 - thiomorpholine-carboxylate dehydrogenase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
-
high enzyme expression level, expression of the CRYM transcript follows the hair growth cycle with a significant increase in expression during mid- and late anagen growth phases
additional information
-
CRYM/KR mRNA in the mouse is most highly expressed in skin among the tissues evaluated, followed by brain and heart
-
very low expression in cerebellum compared to cerebrum, high overall expression level
-
levels of thyroid hormone binding capacity for cytosolic NADPH-dependent T3 binding are noticeably lower in the cerebellum than in the cerebrum of adult rat brain at all stages of development. NADPH-dependent T3 binding is only detected in kidney, liver, heart and spleen after birth, increasing over the next 6 weeks. NADPH-dependent T3 binding is detected in cerebrum and cerebellum 5 days before birth, increasing with a sharp transient spike at the time of birth, that is specific for the brain, particularly in cerebrum, and cannot be seen in other tissues. The NADPH-dependent T3 binding in cerebrum decreases after birth, but begins to increase again 2 weeks after birth. The level in cerebellum does not show this increase. The brain may contain at least two distinct P2C reductases/ketimine reductase, one of which is predominant in the fore-brain and another that is prominent in the cerebellum